BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Thyroid cancer AND CASP8, ALPS2B, 841, ENSG00000064012, MGC78473, CAP4, MACH, MCH5, FLICE AND Prognosis
6 results:

  • 1. Evaluation of the anticancer effect of telomerase inhibitor BIBR1532 in anaplastic thyroid cancer in terms of apoptosis, migration and cell cycle.
    Turkmen E; Sogutlu F; Erdogan M; Biray Avci C
    Med Oncol; 2023 Jun; 40(7):196. PubMed ID: 37284891
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. machine learning-based model for prediction and feature analysis of recurrence in pancreatic neuroendocrine tumors G1/G2.
    Murakami M; Fujimori N; Nakata K; Nakamura M; Hashimoto S; Kurahara H; Nishihara K; Abe T; Hashigo S; Kugiyama N; Ozawa E; Okamoto K; Ishida Y; Okano K; Takaki R; Shimamatsu Y; Ito T; Miki M; Oza N; Yamaguchi D; Yamamoto H; Takedomi H; Kawabe K; Akashi T; Miyahara K; Ohuchida J; Ogura Y; Nakashima Y; Ueki T; Ishigami K; Umakoshi H; Ueda K; Oono T; Ogawa Y
    J Gastroenterol; 2023 Jun; 58(6):586-597. PubMed ID: 37099152
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Value of clinical features combined with multimodal ultrasound in predicting lymph node metastasis in cervical central area of papillary thyroid carcinoma.
    Xue J; Li S; Qu N; Wang G; Chen H; Wu Z; Cao X
    J Clin Ultrasound; 2023 Jun; 51(5):908-918. PubMed ID: 37058552
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Value of lymph node ratio as a prognostic factor of recurrence in medullary thyroid cancer.
    Hao W; Zhao J; Guo F; Gu P; Zhang J; Huang D; Ruan X; Zeng Y; Zheng X; Gao M
    PeerJ; 2023; 11():e15025. PubMed ID: 36935920
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. A model based on clinical data and multi-modal ultrasound for predicting cervical lymph node metastasis in patients with thyroid papillary carcinoma.
    Wang B; Cao Q; Cui XW; Dietrich CF; Yi AJ
    Front Endocrinol (Lausanne); 2022; 13():1063998. PubMed ID: 36578956
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.
    He HC; Kashat L; Kak I; Kunavisarut T; Gundelach R; Kim D; So AK; MacMillan C; Freeman JL; Ralhan R; Walfish PG
    PLoS One; 2012; 7(9):e42893. PubMed ID: 23049733
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.